Medexus Pharmaceuticals Inc. (OTCMKTS:PDDPF – Get Free Report)’s share price was down 33.5% during mid-day trading on Monday . The company traded as low as $2.11 and last traded at $2.14. Approximately 39,966 shares were traded during mid-day trading, an increase of 818% from the average daily volume of 4,355 shares. The stock had previously closed at $3.22.
Medexus Pharmaceuticals Stock Performance
The company has a 50 day simple moving average of $2.14 and a 200 day simple moving average of $2.14.
About Medexus Pharmaceuticals
Medexus Pharmaceuticals, Inc operates as a pharmaceutical company. It provide healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The company products include Rasuvo, Metoject and Rupall. Medexus was founded by Sylvain Chretien in January 2008 and is headquartered in Verdun, Canada.
Further Reading
- Five stocks we like better than Medexus Pharmaceuticals
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- The Average 401k Balance by Age Explained
- What is the Hang Seng index?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Market Cap Calculator: How to Calculate Market Cap
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
